Alignment Healthcare to Participate in the 2023 Morgan Stanley C-Suite Call Series

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ORANGE, Calif., March 13, 2023 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will participate in Morgan Stanley’s 2023 Healthcare Services & Technology C-Suite Call Series, held virtually at noon EDT on Thursday, March 16.

A live webcast of the conversation will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/. There will be no replay available.

About Alignment Health
Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health is a tech-enabled Medicare Advantage company that offers more than 40 benefits-rich, value-driven plans that serve 52 counties across six states. The company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. Based in California, the company’s mission-focused team makes high-quality, low-cost care a reality for members every day. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.

Investor Contact
Harrison Zhuo
hzhuo@ahcusa.com

Media Contact
Maggie Habib
mPR, Inc. for Alignment Healthcare
alignment@mpublicrelations.com

Staff

Recent Posts

Havas Health Network and Republica Havas Health Unveil Report on Inequities in HCP Training and Practices

"The Hidden Divide" Exposes Gaps in Healthcare Provider Education and Care Delivery MIAMI, April 21,…

2 hours ago

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors

NAGOYA, Japan, April 21, 2025 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced…

2 hours ago

Zimmer Biomet Completes Acquisition of Paragon 28

Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment WARSAW, Ind., April 21, 2025…

2 hours ago

CathVision to Exhibit the Latest Advancements in Electrophysiology at Heart Rhythm Society 2025 in San Diego

COPENHAGEN, Denmark, April 21, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP)…

2 hours ago

DarioHealth Announces CFO Transition

NEW YORK, April 21, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a…

2 hours ago

BGM Group Acquires Wonder Dragon to Accelerate “Healthcare” Strategy

CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that…

2 hours ago